These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 16874533)

  • 21. Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis.
    Vaia M; Petrosino S; De Filippis D; Negro L; Guarino A; Carnuccio R; Di Marzo V; Iuvone T
    Eur J Pharmacol; 2016 Nov; 791():669-674. PubMed ID: 27720681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis.
    Herzog JL; Solomon JA; Draelos Z; Fleischer A; Stough D; Wolf DI; Abramovits W; Werschler W; Green E; Duffy M; Rothaul A; Tansley R
    J Drugs Dermatol; 2011 Aug; 10(8):853-60. PubMed ID: 21818506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Pruritic Efficacy of Itch Relief Lotion and Cream in Patients With Atopic History: Comparison With Hydrocortisone Cream.
    Zirwas MJ; Barkovic S
    J Drugs Dermatol; 2017 Mar; 16(3):243-247. PubMed ID: 28301620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Topical administration of capsaicin in dermatology for treatment of itching and pain].
    Reimann S; Luger T; Metze D
    Hautarzt; 2000 Mar; 51(3):164-72. PubMed ID: 10789077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patients.
    Young TA; Patel TS; Camacho F; Clark A; Freedman BI; Kaur M; Fountain J; Williams LL; Yosipovitch G; Fleischer AB
    J Dermatolog Treat; 2009; 20(2):76-81. PubMed ID: 18821119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of pain initiation by endogenous cannabinoids.
    Calignano A; La Rana G; Giuffrida A; Piomelli D
    Nature; 1998 Jul; 394(6690):277-81. PubMed ID: 9685157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipruritic mechanisms of topical E6005, a phosphodiesterase 4 inhibitor: inhibition of responses to proteinase-activated receptor 2 stimulation mediated by increase in intracellular cyclic AMP.
    Andoh T; Kuraishi Y
    J Dermatol Sci; 2014 Dec; 76(3):206-13. PubMed ID: 25458869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the German guideline for chronic pruritus: results of a retrospective study on 385 patients.
    Siepmann D; Weishaupt C; Luger TA; Ständer S
    Dermatology; 2011; 223(4):374-80. PubMed ID: 22301826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thalidomide for the treatment of chronic refractory pruritus.
    Sharma D; Kwatra SG
    J Am Acad Dermatol; 2016 Feb; 74(2):363-9. PubMed ID: 26577510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
    Romero TR; Resende LC; Guzzo LS; Duarte ID
    Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic effect of topical gamma-linolenic acid on refractory uremic pruritus.
    Chen YC; Chiu WT; Wu MS
    Am J Kidney Dis; 2006 Jul; 48(1):69-76. PubMed ID: 16797388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical amitriptyline combined with topical ketamine for the management of recalcitrant localized pruritus: a retrospective pilot study.
    Poterucha TJ; Murphy SL; Sandroni P; Rho RH; Warndahl RA; Weiss WT; Davis MD
    J Am Acad Dermatol; 2013 Aug; 69(2):320-1. PubMed ID: 23866874
    [No Abstract]   [Full Text] [Related]  

  • 33. Antipruritic treatment with systemic μ-opioid receptor antagonists: a review.
    Phan NQ; Bernhard JD; Luger TA; Ständer S
    J Am Acad Dermatol; 2010 Oct; 63(4):680-8. PubMed ID: 20462660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low density of sympathetic nerve fibers relative to substance P-positive nerve fibers in lesional skin of chronic pruritus and prurigo nodularis.
    Haas S; Capellino S; Phan NQ; Böhm M; Luger TA; Straub RH; Ständer S
    J Dermatol Sci; 2010 Jun; 58(3):193-7. PubMed ID: 20417061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermittent use of topical dimethyl sulfoxide in macular and papular amyloidosis.
    Ozkaya-Bayazit E; Kavak A; Güngör H; Ozarmagan G
    Int J Dermatol; 1998 Dec; 37(12):949-54. PubMed ID: 9888342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic pruritus: targets, mechanisms and future therapies.
    Pogatzki-Zahn E; Marziniak M; Schneider G; Luger TA; Ständer S
    Drug News Perspect; 2008 Dec; 21(10):541-51. PubMed ID: 19221635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Small fiber neuropathy as a possible cause for chronic pruritus].
    Pereira MP; Mühl S; Ständer S
    Hautarzt; 2016 Aug; 67(8):615-21. PubMed ID: 27315103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pruritus in frequent skin diseases and therapeutic options].
    Ballmer-Weber BK; Dummer R
    Praxis (Bern 1994); 2007 Jan; 96(4):107-11. PubMed ID: 17294586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pruritus: an overview of current concepts.
    Metz M; Grundmann S; Ständer S
    Vet Dermatol; 2011 Apr; 22(2):121-31. PubMed ID: 21251097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.
    Rigopoulos D; Ioannides D; Kalogeromitros D; Gregoriou S; Katsambas A
    Br J Dermatol; 2004 Nov; 151(5):1071-5. PubMed ID: 15541087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.